Molecular Genetics and Metabolism Reports最新文献

{"title":"Survival of propionic acidemia patients with liver transplant","authors":"Tamás Zelei ,&nbsp;Zoltán Vokó ,&nbsp;Bertalan Németh ,&nbsp;Zsuzsanna Petykó ,&nbsp;Geetanjoli Banerjee ,&nbsp;Vanja Sikirica","doi":"10.1016/j.ymgmr.2024.101093","DOIUrl":"https://doi.org/10.1016/j.ymgmr.2024.101093","url":null,"abstract":"<div><p>Propionic acidemia (PA) is a rare metabolic disorder affecting amino acid metabolism. Liver transplantation improves some outcomes, but the impact on long-term survival remains unclear. A systematic literature review and survival analysis, identifying 94 PA patients who underwent transplantation, revealed a survival probability of 62% at age 33; while median survival was estimated at 40 years. These findings highlight a substantial survival deficit of PA patients compared to the general population despite liver transplantation.</p></div>","PeriodicalId":18814,"journal":{"name":"Molecular Genetics and Metabolism Reports","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214426924000466/pdfft?md5=6ec3e96415b28a745f8edd1bd940d8d1&pid=1-s2.0-S2214426924000466-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141164513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessing the lived experiences of females with phenylketonuria in their health management","authors":"Abigail Aronoff ,&nbsp;Yue Guan ,&nbsp;Saran Gurung ,&nbsp;Dawn L. Comeau ,&nbsp;Rani H. Singh","doi":"10.1016/j.ymgmr.2024.101095","DOIUrl":"https://doi.org/10.1016/j.ymgmr.2024.101095","url":null,"abstract":"<div><h3>Introduction</h3><p>The present study is a mixed-methods exploratory study aiming to understand the lived experiences of females with phenylketonuria (PKU) in managing their health. The study aims to identify what individual, interpersonal, and environmental factors serve as facilitators and inhibitors, and how PKU intrudes on different realms of health.</p></div><div><h3>Methods</h3><p>Attendees of Emory's Metabolic Camp and female users of Medical Nutrition Therapy for Prevention (MNT4P) were recruited. Participants were administered the Illness Intrusiveness Ratings Scale (IIRS) survey and qualitatively interviewed. The IIRS survey was analyzed using descriptive statistics and the interviews were coded and assessed using inductive and deductive analysis.</p></div><div><h3>Results</h3><p>In total, 25 participants were included in analysis (adults, <em>n</em> = 20; adolescents, <em>n</em> = 5). In the IIRS survey, diet had the highest average impact score of 5.74 (SD = 2.05) and religious expression had the lowest average impact score of 1.74 (SD = 1.65). The most salient themes that arose from the qualitative interviews were related to concerns of pregnancy (<em>n</em> = 25), interactions with health care providers relative to PKU care (<em>n</em> = 23) and independent of PKU care (<em>n</em> = 21), social support (n = 21) and isolation (<em>n</em> = 12), financial issues (<em>n</em> = 22), and illness intrusiveness on general health management (n = 22).</p></div><div><h3>Discussion</h3><p>Adolescent and adult female participants with PKU identified significant concerns in individual, interpersonal, and environmental factors affecting the management of their health. Additionally, the illness intrusiveness of PKU impacted their physical, mental, and gynecological health. Future research should further assess the unique challenges faced by females with PKU and potential interventions to better address these barriers.</p></div>","PeriodicalId":18814,"journal":{"name":"Molecular Genetics and Metabolism Reports","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S221442692400048X/pdfft?md5=299312513a01398fb97c3cd785afefe6&pid=1-s2.0-S221442692400048X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141095586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Joint replacement risk is markedly increased in alkaptonuria (AKU) in those with prior arthroplasty","authors":"L.R. Ranganath ,&nbsp;M. Khedr ,&nbsp;B.P. Norman ,&nbsp;J.H. Hughes ,&nbsp;R. Imrich ,&nbsp;J.B. Arnoux ,&nbsp;B. Olsson ,&nbsp;M. Rudebeck ,&nbsp;J.A. Gallagher ,&nbsp;G. Bou-Gharios","doi":"10.1016/j.ymgmr.2024.101097","DOIUrl":"https://doi.org/10.1016/j.ymgmr.2024.101097","url":null,"abstract":"<div><h3>Background</h3><p>Increased homogentisic acid (HGA) in alkaptonuria (AKU) causes severe arthritis. Nitisinone reduces the production of HGA, but whether it also decreases arthroplasty was examined in 237 AKU patients.</p></div><div><h3>Patients and methods</h3><p>Patients attending the United Kingdom National Alkaptonuria Centre (NAC) and the Suitability of Nitisinone in Alkaptonuria 2 (SONIA 2) study were studied. Assessments included questionnaires eliciting details of arthroplasty. Nitisinone was administered from baseline, 2 mg in the NAC and 10 mg in SONIA 2. In SONIA 2, subgroups consisted of those with baseline arthroplasty on and not on nitisinone (BR + N+, BR + N-), as well as those without baseline arthroplasty on and not on nitisinone (BR-N+, BR-N-).</p></div><div><h3>Results</h3><p>In the SONIA2 subgroups, new joint replacement (JR) probabilities after baseline were significantly different (BR + N+, BR + N-, BR-N+, BR-N-) (χ² = 23.3, <em>p</em> &lt; 0.001); mean (SD) was 3.8 (0.1) years in BR-N-, 3.7 (0.1) years in BR-N+, 3.4 (0.3) years in BR + N-, and 3.0 (0.3) years in BR + N+. Further, the BR + N- showed more JR than the BR-N- subgroup (<em>p</em> &lt; 0.01), while BR + N+ similarly showed more JR than the BR-N+ subgroup (<em>p</em> &lt; 0.001).</p><p>In the NAC, the BR- group had a mean age of 51.6 <strong>(</strong>7.0) years at baseline but 57.7 (8.7) years at final follow up during nitisinone therapy and showed only 7 incident JR. The BR+ group had an age at baseline of 57.4 (8.5) years and had undergone 94 JRs at baseline.</p></div><div><h3>Conclusion</h3><p>The incidence of arthroplasty was earlier and more frequent after the first JR and was not affected by nitisinone.</p></div>","PeriodicalId":18814,"journal":{"name":"Molecular Genetics and Metabolism Reports","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214426924000508/pdfft?md5=257d0d5a7d314b15aa8620cb17e3c872&pid=1-s2.0-S2214426924000508-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141095587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Characteristics and outcomes of pregnancies among women with phenylketonuria from the NBS Connect registry","authors":"Aileen Kenneson ,&nbsp;Margite I. Borth ,&nbsp;Rani H. Singh","doi":"10.1016/j.ymgmr.2024.101092","DOIUrl":"https://doi.org/10.1016/j.ymgmr.2024.101092","url":null,"abstract":"<div><p>Women with phenylketonuria (PKU) should maintain blood phenylalanine (phe) concentration within the recommended range before and during pregnancy to prevent maternal PKU syndrome (MPKUS) in their offspring. Women who gave birth to children with MPKUS symptoms were more likely to report elevated phe concentration before pregnancy, and barriers to accessing components of their dietary management during pregnancy, including blood phe testing, medical food, modified low-protein foods, and healthcare visits with PKU specialists.</p></div>","PeriodicalId":18814,"journal":{"name":"Molecular Genetics and Metabolism Reports","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214426924000454/pdfft?md5=a9a6ed8b0503209cdde1cac55173b793&pid=1-s2.0-S2214426924000454-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141066902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of ZBTB38 gene polymorphism (rs724016) with height and fetal hemoglobin in individuals with sickle cell anemia","authors":"Domício Antônio Costa-Júnior ,&nbsp;Thaisa N. Souza Valente ,&nbsp;André Rolim Belisário ,&nbsp;Gisele Queiroz Carvalho ,&nbsp;Miguel Madeira ,&nbsp;Cibele Velloso-Rodrigues","doi":"10.1016/j.ymgmr.2024.101086","DOIUrl":"https://doi.org/10.1016/j.ymgmr.2024.101086","url":null,"abstract":"<div><h3>Objectives</h3><p>Our study evaluated the association of the polymorphism rs724016 in the <em>ZBTB38</em> gene, previously associated with height in other populations, with predictors of height, clinical outcomes, and laboratory parameters in sickle cell anemia (SCA).</p></div><div><h3>Methods</h3><p>Cross-sectional study with individuals with SCA and aged between 3 and 20 years. Clinical, laboratory, molecular, and bone age (BA) data were evaluated. Levels of IGF-1 and IGFBP-3 were adjusted for BA, target height (TH) was calculated as the mean parental height standard deviation score (SDS), and predicted adult height (PAH) SDS was calculated using BA.</p></div><div><h3>Results</h3><p>We evaluated 80 individuals with SCA. The homozygous genotype of the G allele of rs724016 was associated with a lower height SDS (<em>p</em> &lt; 0.001) and, in a additive genetic model, was negatively associated with HbF levels (<em>p</em> = 0.016). Lower adjusted IGF-1 levels were associated with co-inheritance of alpha-thalassemia and with the absence of HU therapy. Elevated HbF levels were associated with a lower deficit in adjusted growth potential (TH minus PAH).</p></div><div><h3>Conclusion</h3><p>Our analysis shows that SNP rs724016 in the <em>ZBTB38</em> is associated with shorter height and lower HbF levels, an important modifier of SCA.</p></div>","PeriodicalId":18814,"journal":{"name":"Molecular Genetics and Metabolism Reports","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214426924000399/pdfft?md5=da3bbf76e9ed4fae8d5f2bdbfd799747&pid=1-s2.0-S2214426924000399-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140951911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Partial suppression of BCAA catabolism as a potential therapy for BCKDK deficiency","authors":"Laura Ohl ,&nbsp;Amanda Kuhs ,&nbsp;Ryan Pluck ,&nbsp;Emily Durham ,&nbsp;Michael Noji ,&nbsp;Nathan D. Philip ,&nbsp;Zoltan Arany ,&nbsp;Rebecca C. Ahrens-Nicklas","doi":"10.1016/j.ymgmr.2024.101091","DOIUrl":"https://doi.org/10.1016/j.ymgmr.2024.101091","url":null,"abstract":"<div><p>Branched chain ketoacid dehydrogenase kinase (BCKDK) deficiency is a recently described inherited neurometabolic disorder of branched chain amino acid (BCAA) metabolism implying increased BCAA catabolism. It has been hypothesized that a severe reduction in systemic BCAA levels underlies the disease pathophysiology, and that BCAA supplementation may ameliorate disease phenotypes. To test this hypothesis, we characterized a recent mouse model of BCKDK deficiency and evaluated the efficacy of enteral BCAA supplementation in this model. Surprisingly, BCAA supplementation exacerbated neurodevelopmental deficits and did not correct biochemical abnormalities despite increasing systemic BCAA levels. These data suggest that aberrant flux through the BCAA catabolic pathway, not just BCAA insufficiency, may contribute to disease pathology. In support of this conclusion, genetic re-regulation of BCAA catabolism, through <em>Dbt</em> haploinsufficiency, partially rescued biochemical and behavioral phenotypes in BCKDK deficient mice. Collectively, these data raise into question assumptions widely made about the pathophysiology of BCKDK insufficiency and suggest a novel approach to develop potential therapies for this disease.</p></div>","PeriodicalId":18814,"journal":{"name":"Molecular Genetics and Metabolism Reports","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214426924000442/pdfft?md5=b366c7af33522baac93e042133fb1637&pid=1-s2.0-S2214426924000442-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140901863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Poor adherence during adolescence is a risk factor for becoming lost-to-follow-up in patients with phenylketonuria","authors":"Marianna Beghini ,&nbsp;Maximilian Pichler ,&nbsp;Fiona Carolina Tinnefeld ,&nbsp;Matthäus Metz ,&nbsp;Dorothea Möslinger ,&nbsp;Vassiliki Konstantopoulou ,&nbsp;Johannes Spenger ,&nbsp;Alexandra Kautzky-Willer ,&nbsp;Florian Frommlet ,&nbsp;Thomas Scherer ,&nbsp;Miriam Hufgard-Leitner","doi":"10.1016/j.ymgmr.2024.101087","DOIUrl":"https://doi.org/10.1016/j.ymgmr.2024.101087","url":null,"abstract":"<div><h3>Purpose</h3><p>A high rate of lost to follow-up (LTFU) in patients with phenylketonuria (PKU) represents a main challenge. In this study, we investigated potential risk factors for becoming LTFU related to adolescence as a critical period of life.</p></div><div><h3>Methods</h3><p>We retrospectively analyzed longitudinal data collected from 1993 to 2019 of patients diagnosed with classic PKU that were followed at our center during adolescence (14–18 y) and at least once in adulthood (&gt;18 y). Patients who interrupted their contact with our center after the 18th birthday for at least 2 years were classified as LTFU. We performed a multivariate regression analysis to investigate following potential risk factors for becoming LTFU in adult life: sex, dietary compliance during adolescence assessed through the mean of the annual medians of phenylalanine plasma values, average number of contacts with the center during adolescence and age at first visit after the 18th birthday.</p></div><div><h3>Results</h3><p>93 patients (52 males, 41 females) were included in the study. 58% became LTFU during adulthood. The mean age at the last visit before becoming LTFU was 26.2 ± 5.1 years. In the multivariate Cox regression analysis we found that poor dietary compliance during adolescence was significantly associated with a higher risk of becoming LTFU during adulthood (<em>p</em>-value = 0.028).</p></div><div><h3>Discussion</h3><p>Adult patients who displayed poor treatment adherence during adolescence should be identified and carefully monitored to prevent loss of contact.</p></div>","PeriodicalId":18814,"journal":{"name":"Molecular Genetics and Metabolism Reports","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214426924000405/pdfft?md5=1508159e8abde38b8437ef90f76e7cfe&pid=1-s2.0-S2214426924000405-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140894631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Severe heart failure in a unique case of cobalamin-C-deficiency resolved with LVAD implantation and subsequent heart transplantation","authors":"Clara Hjalmarsson ,&nbsp;Charlotte Backelin ,&nbsp;Anders Thoren ,&nbsp;Niklas Bergh ,&nbsp;Jennifer L. Sloan ,&nbsp;Irini Manoli ,&nbsp;Charles P. Venditti ,&nbsp;Göran Dellgren","doi":"10.1016/j.ymgmr.2024.101089","DOIUrl":"https://doi.org/10.1016/j.ymgmr.2024.101089","url":null,"abstract":"<div><p>Introduction</p><p>Cobalamin c deficiency (cblC), an inborn error of vitamin B12 metabolism, is caused by mutations of the MMACHC gene. It usually leads to a multisystemic disease; 50% of all patients with cblC have various structural heart defects. Severe congestive heart failure (HF) may also occur and its prognosis is poorly documented.</p><p>Case report</p><p>We present the case of a young man who had been diagnosed with cblC due to C331T mutation in the MMACHC gene at the age of 3 days and had been treated with substitution therapy (OH-Cbl, mecobalamine, carnitine, betaine, and calcium folinate) since then. He had mildly impaired cognitive function; an ectopic hypophysis/pituitary insufficiency, with adequate hormone replacement therapy; obstructive sleep apnea syndrome, treated with CPAP, bronchial asthma, and obesity (BMI of 30). The liver and kidney functions were normal. He developed severe dilated cardiomyopathy and HF at the age of 12y. With medical treatment, his condition improved and he was stable (NYHA class II) for several years. Six years later, his status deteriorated rapidly, as he developed advanced HF, INTERMACS 3. The cardiac ultrasound revealed dilated ventricles with severely depressed ejection fraction (EF), increased filling pressures, and pulmonary hypertension (sPAP 60 mmHg). Cardiac MRI showed extremely dilated chambers (LVedv 609 mL, RVedv 398 mL) with pronounced non-compaction, and a left ventricle EF of 13%. A primary prophylactic ICD and a left ventricular assist device (LVAD/HM3) were implanted, and the patient was subsequently listed for heart transplantation (HTx). After 25 months on the waiting list, he underwent an uncomplicated HTx. However postoperatively, he got two episodes of cardiac tamponade, as well as mediastinitis, treated with antibiotics and vaccum assisted closure. He developed severe kidney failure, which fully recovered after two months, and was treated successfully for an early moderate allograft rejection (ISHT 2). At the latest outward visit, twelve months after HTx, the patient was doing excellent.</p><p>Summary</p><p>To the best of our knowledge, this is the first ever reported case of a patient with CblC undergoing an LVAD implantation and subsequently a HTx. Although both interventions were complicated with bleeding events, this seems to be a treatment option for advanced HF in patients with CblC.</p></div>","PeriodicalId":18814,"journal":{"name":"Molecular Genetics and Metabolism Reports","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214426924000429/pdfft?md5=57ecc307f8f8a2677d25b1c08565f0d8&pid=1-s2.0-S2214426924000429-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140879378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Newborn screening for isovaleric acidemia: A case report of a Chinese patient with novel variants","authors":"Huizhong Li,&nbsp;Fang Shao,&nbsp;Wei Zhou","doi":"10.1016/j.ymgmr.2024.101088","DOIUrl":"https://doi.org/10.1016/j.ymgmr.2024.101088","url":null,"abstract":"<div><p>Isovaleric acidemia (IVA) is a rare autosomal recessive disorder that manifests as a deficiency of isovaleryl-CoA dehydrogenase (IVD), a key enzyme in leucine metabolism. The clinical presentations associated with IVD deficiency are variable and include feeding intolerance, vomiting, metabolic acidosis, ketonemia, “sweaty feet” odor, lethargy, coma and even death. Tandem mass spectrometry (MS/MS) and gas chromatography–mass spectrometry (GC/MS) methods were used to perform organic acid analysis of blood and urine samples from IVA patients, and the genetic analysis included next generation sequencing (NGS) and Sanger sequencing of the <em>IVD</em> gene. Here, we report the case of an almost seven-year-old male patient from a Chinese family who was asymptomatic during the newborn period, including the clinical manifestations and examination results. Genetic analysis revealed a previously unreported compound heterozygous variant in the <em>IVD</em> gene: c.593G &gt; C (p.W198S) and c.859C &gt; T (p.R287W).</p></div>","PeriodicalId":18814,"journal":{"name":"Molecular Genetics and Metabolism Reports","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214426924000417/pdfft?md5=2f05e3baa5460ee91526a2add77e0bdd&pid=1-s2.0-S2214426924000417-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140824132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Acid α-glucosidase (GAA) activity and glycogen content in muscle biopsy specimens of patients with Pompe disease: A systematic review","authors":"Benedikt Schoser ,&nbsp;Nina Raben ,&nbsp;Fatbardha Varfaj ,&nbsp;Mark Walzer ,&nbsp;Antonio Toscano","doi":"10.1016/j.ymgmr.2024.101085","DOIUrl":"https://doi.org/10.1016/j.ymgmr.2024.101085","url":null,"abstract":"<div><p>Pompe disease is a rare genetic disorder characterized by a deficiency of acid α-glucosidase (GAA), leading to the accumulation of glycogen in various tissues, especially in skeletal muscles. The disease manifests as a large spectrum of phenotypes from infantile-onset Pompe disease (IOPD) to late-onset Pompe disease (LOPD), depending on the age of symptoms onset. Quantifying GAA activity and glycogen content in skeletal muscle provides important information about the disease severity. However, the distribution of GAA and glycogen levels in skeletal muscles from healthy individuals and those impacted by Pompe disease remains poorly understood, and there is currently no universally accepted standard assay for GAA activity measurement. This systematic literature review aims to provide an overview of the available information on GAA activity and glycogen content levels in skeletal muscle biopsies from patients with Pompe disease.</p><p>A structured review of PubMed and Google Scholar literature (with the latter used to check that no additional publications were identified) was conducted to identify peer-reviewed publications on glycogen storage disease type II [MeSH term] + GAA, protein human (supplementary concept), Pompe, muscle; and muscle, acid alpha-glucosidase. A limit of English language was applied. Results were grouped by methodologies used to quantify GAA activity and glycogen content in skeletal muscle. The search and selection strategy were devised and carried out in line with Preferred Reporting of Items in Systematic Reviews and Meta-Analysis guidelines and documented using a flowchart. Bibliographies of papers included in the analysis were reviewed and applicable publications not already identified in the search were included.</p><p>Of the 158 articles retrieved, 24 (comprising &gt;100 muscle biopsies from &gt;100 patients) were included in the analysis, with four different assays. Analysis revealed that patients with IOPD exhibited markedly lower GAA activity in skeletal muscles than those with LOPD, regardless of the measurement method employed. Additionally, patients with IOPD had notably higher glycogen content levels in skeletal muscles than those with LOPD. In general, however, it was difficult to fully characterize GAA activity because of the different methods used. The findings underscore the challenges in the interpretation and comparison of the results across studies because of the substantial methodological variations. There is a need to establish standardized reference ranges of GAA activity and glycogen content in healthy individuals and in Pompe disease patients based on globally standardized methods to improve comparability and reliability in assessing this rare disease.</p></div>","PeriodicalId":18814,"journal":{"name":"Molecular Genetics and Metabolism Reports","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214426924000387/pdfft?md5=7a6c91e4ce9647f2b38f21d11da753cc&pid=1-s2.0-S2214426924000387-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140646128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}